vs
Side-by-side financial comparison of FIRST COMMONWEALTH FINANCIAL CORP (FCF) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $133.7M, roughly 1.6× FIRST COMMONWEALTH FINANCIAL CORP). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 28.1%, a 29.3% gap on every dollar of revenue.
First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
FCF vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $133.7M | $207.8M |
| Net Profit | $37.5M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | — | 52.2% |
| Net Margin | 28.1% | 57.4% |
| Revenue YoY | 13.0% | — |
| Net Profit YoY | 14.8% | 330.1% |
| EPS (diluted) | $0.37 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $133.7M | — | ||
| Q4 25 | $137.9M | — | ||
| Q3 25 | $136.0M | $207.8M | ||
| Q2 25 | $131.0M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $120.4M | — | ||
| Q3 24 | $121.2M | $0 | ||
| Q2 24 | $120.2M | $0 |
| Q1 26 | $37.5M | — | ||
| Q4 25 | $44.9M | — | ||
| Q3 25 | $41.3M | $119.2M | ||
| Q2 25 | $33.4M | — | ||
| Q1 25 | $32.7M | — | ||
| Q4 24 | $35.8M | — | ||
| Q3 24 | $32.1M | $-51.8M | ||
| Q2 24 | $37.1M | $-52.8M |
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | — | ||
| Q3 25 | 38.1% | 52.2% | ||
| Q2 25 | 32.1% | — | ||
| Q1 25 | 34.8% | — | ||
| Q4 24 | 37.1% | — | ||
| Q3 24 | 33.4% | — | ||
| Q2 24 | 38.7% | — |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 32.5% | — | ||
| Q3 25 | 30.4% | 57.4% | ||
| Q2 25 | 25.5% | — | ||
| Q1 25 | 27.7% | — | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 26.5% | — | ||
| Q2 24 | 30.9% | — |
| Q1 26 | $0.37 | — | ||
| Q4 25 | $0.44 | — | ||
| Q3 25 | $0.39 | $1.33 | ||
| Q2 25 | $0.32 | — | ||
| Q1 25 | $0.32 | — | ||
| Q4 24 | $0.35 | — | ||
| Q3 24 | $0.31 | $-0.60 | ||
| Q2 24 | $0.36 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $786.9M |
| Total DebtLower is stronger | $154.9M | — |
| Stockholders' EquityBook value | $1.6B | $1.1B |
| Total Assets | $12.3B | $1.2B |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $786.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | — | $701.7M |
| Q1 26 | $154.9M | — | ||
| Q4 25 | $261.7M | — | ||
| Q3 25 | $262.1M | — | ||
| Q2 25 | $262.4M | — | ||
| Q1 25 | $262.7M | — | ||
| Q4 24 | $263.0M | — | ||
| Q3 24 | $136.3M | — | ||
| Q2 24 | $136.6M | — |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.5B | $1.1B | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.4B | $931.7M |
| Q1 26 | $12.3B | — | ||
| Q4 25 | $12.3B | — | ||
| Q3 25 | $12.3B | $1.2B | ||
| Q2 25 | $12.2B | — | ||
| Q1 25 | $11.8B | — | ||
| Q4 24 | $11.6B | — | ||
| Q3 24 | $12.0B | $1.2B | ||
| Q2 24 | $11.6B | $973.7M |
| Q1 26 | 0.10× | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.18× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $187.5M | — | ||
| Q3 25 | $49.5M | $142.2M | ||
| Q2 25 | $30.4M | — | ||
| Q1 25 | $55.9M | — | ||
| Q4 24 | $129.5M | — | ||
| Q3 24 | $53.6M | $-49.2M | ||
| Q2 24 | $22.7M | $-32.9M |
| Q1 26 | — | — | ||
| Q4 25 | $171.5M | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $113.9M | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M |
| Q1 26 | — | — | ||
| Q4 25 | 124.3% | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 94.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 12.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.18× | — | ||
| Q3 25 | 1.20× | 1.19× | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 1.71× | — | ||
| Q4 24 | 3.61× | — | ||
| Q3 24 | 1.67× | — | ||
| Q2 24 | 0.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
